Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleftherios Mylonakis

Showing results (401-410 of 412) with videos related to

Pageof 42
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 8, 2025
Long-term outcomes of passive immunotherapy for COVID-19: a pooled analysis of a large multinational platform randomized clinical trialAhmad Mourad, Gregory A Grandits, Lianne K Siegel, et al.
The Journal of Infectious Diseases|July 27, 2022
Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19Selin Somersan-Karakaya, Eleftherios Mylonakis, Vidya P Menon, et al.
Obesity (Silver Spring, Md.)|May 9, 2021
BMI and pneumonia outcomes in critically ill covid-19 patients: An international multicenter studyMikael Chetboun, Violeta Raverdy, Julien Labreuche, et al.
The Lancet. Microbe|May 30, 2024
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort studyTomas O Jensen, Thomas A Murray, Greg A Grandits, et al.
Med (New York, N.Y.)|August 13, 2022
Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO)Eleftherios Mylonakis, Joseph Lutaakome, Mamta K Jain, et al.
The Journal of Infectious Diseases|November 10, 2023
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19Tomas O Jensen, Greg A Grandits, Mamta K Jain, et al.
Clinical and Translational Medicine|May 6, 2022
Topical niclosamide (ATx201) reduces Staphylococcus aureus colonization and increases Shannon diversity of the skin microbiome in atopic dermatitis patients in a randomized, double-blind, placebo-controlled Phase 2 trialAnne Weiss, Emilie Delavenne, Carina Matias, et al.
Scientific Reports|March 22, 2025
SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial)Sofía Sábato, Susana Benet, Angela J Rogers, et al.
The Journal of Infectious Diseases|September 13, 2024
Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019Cavan Reilly, Eleftherios Mylonakis, Robin Dewar, et al.
Annals of Internal Medicine|August 29, 2022
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19, Angela J Rogers, Deborah Wentworth, et al.
Pageof 42

Showing results (401-410 of 412) with videos related to

Sort By:
Pageof 42
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 8, 2025
Long-term outcomes of passive immunotherapy for COVID-19: a pooled analysis of a large multinational platform randomized clinical trialAhmad Mourad, Gregory A Grandits, Lianne K Siegel, et al.
The Journal of Infectious Diseases|July 27, 2022
Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19Selin Somersan-Karakaya, Eleftherios Mylonakis, Vidya P Menon, et al.
Obesity (Silver Spring, Md.)|May 9, 2021
BMI and pneumonia outcomes in critically ill covid-19 patients: An international multicenter studyMikael Chetboun, Violeta Raverdy, Julien Labreuche, et al.
The Lancet. Microbe|May 30, 2024
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort studyTomas O Jensen, Thomas A Murray, Greg A Grandits, et al.
Med (New York, N.Y.)|August 13, 2022
Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO)Eleftherios Mylonakis, Joseph Lutaakome, Mamta K Jain, et al.
The Journal of Infectious Diseases|November 10, 2023
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19Tomas O Jensen, Greg A Grandits, Mamta K Jain, et al.
Clinical and Translational Medicine|May 6, 2022
Topical niclosamide (ATx201) reduces Staphylococcus aureus colonization and increases Shannon diversity of the skin microbiome in atopic dermatitis patients in a randomized, double-blind, placebo-controlled Phase 2 trialAnne Weiss, Emilie Delavenne, Carina Matias, et al.
Scientific Reports|March 22, 2025
SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial)Sofía Sábato, Susana Benet, Angela J Rogers, et al.
The Journal of Infectious Diseases|September 13, 2024
Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019Cavan Reilly, Eleftherios Mylonakis, Robin Dewar, et al.
Annals of Internal Medicine|August 29, 2022
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19, Angela J Rogers, Deborah Wentworth, et al.
Pageof 42